USEFULNESS OF SERUM MICRORNAS AS BIOMARKERS FOR PEDIATRIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

被引：0
作者：
Blakley, Caroline [1 ]
Nelson, Benjamin [2 ]
Qarooni, Shatha [3 ]
Lee, Wai Han [3 ]
Tryggestad, Jeanie [3 ]
Short, Kevin [3 ]
Palle, Sirish Kumar [3 ]
机构：
[1] Univ Oklahoma, Hlth & Sci Ctr, Norman, OK USA
[2] Harold Hamm Diabet Ctr HHDC, Norman, OK USA
[3] Univ Oklahoma, Hlth Sci Ctr, OUHSC, Dept Pediat, Norman, OK USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
829
引用
收藏
页码：S626 / S626
页数：1
相关论文
共 50 条
  • [21] Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
    Abdelhameed, Farah
    Kite, Chris
    Lagojda, Lukasz
    Dallaway, Alexander
    Chatha, Kamaljit Kaur
    Chaggar, Surinderjeet S.
    Dalamaga, Maria
    Kassi, Eva
    Kyrou, Ioannis
    Randeva, Harpal S.
    CURRENT OBESITY REPORTS, 2024, 13 (03): : 510 - 531
  • [22] Converging Pathways between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Diabetes in Children
    Faienza, Maria Felicia
    Farella, Ilaria
    Khalil, Mohamad
    Portincasa, Piero
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [23] Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy
    El-Sehrawy, Amr Ali Mohamed Abdelgawwad
    Rashid, Teeba Ammar
    Ullah, Muhammad Ikram
    Uthirapathy, Subasini
    Ganesan, Subbulakshmi
    Singh, Abhayveer
    Devi, Anita
    Joshi, Kamal Kant
    Jasim, Ahmed Salman
    Kadhim, Abed J.
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2025, 25 (01)
  • [24] METALD, THE NEW CATEGORY OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) - HOW COMMON IS IT?
    Scheetz, Kate
    Kalagara, Sanah
    Vilar-Gomez, Eduardo
    Chalasani, Naga P.
    Vuppalanchi, Raj
    GASTROENTEROLOGY, 2024, 166 (05) : S477 - S478
  • [25] Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications
    Liu, J.
    Chen, Y.
    Qian, J.
    Cui, R.
    Demirkan, A.
    Zheng, Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [26] Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Shin, Soyeon
    Kim, Jaeyoung
    Lee, Ju Yeon
    Kim, Jun
    Oh, Chang-Myung
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (04) : 289 - 302
  • [27] Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings
    Iruzubieta, Paula
    Santos-Laso, Alvaro
    Arias-Loste, Maria Teresa
    Calleja, Jose Luis
    Crespo, Javier
    JOURNAL OF HEPATOLOGY, 2024, 80 (03) : e121 - e123
  • [28] Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance
    Hutchison, Alan L.
    Tavaglione, Federica
    Romeo, Stefano
    Charlton, Michael
    JOURNAL OF HEPATOLOGY, 2023, 79 (06) : 1524 - 1541
  • [29] HEALTHCARE PROVIDERS' PERSPECTIVES ON NEW METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) NOMENCLATURE
    Albhaisi, Somaya
    Albhaisi, Omar
    HEPATOLOGY, 2024, 80 : S890 - S891
  • [30] Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights
    Aggeletopoulou, Ioanna
    Tsounis, Efthymios P.
    Triantos, Christos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
12345